Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $165000.0.

  • Biomerica's Long-Term Investments changed 0.0% to $165000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $165000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $165000.0 for FY2025, which is 0.0% changed from last year.
  • Biomerica's Long-Term Investments amounted to $165000.0 in Q4 2025, which was down 0.0% from $165000.0 recorded in Q3 2025.
  • Biomerica's 5-year Long-Term Investments high stood at $165324.0 for Q1 2021, and its period low was $165000.0 during Q2 2022.
  • Over the past 5 years, Biomerica's median Long-Term Investments value was $165000.0 (recorded in 2022), while the average stood at $165129.6.
  • Per our database at Business Quant, Biomerica's Long-Term Investments changed by 0.0% in 2021 and then dropped by 19.6% in 2022.
  • Biomerica's Long-Term Investments (Quarter) stood at $165324.0 in 2021, then changed by 0.0% to $165324.0 in 2022, then dropped by 0.2% to $165000.0 in 2023, then changed by 0.0% to $165000.0 in 2024, then changed by 0.0% to $165000.0 in 2025.
  • Its Long-Term Investments stands at $165000.0 for Q4 2025, versus $165000.0 for Q3 2025 and $165000.0 for Q2 2025.